|
⚲
|
| Keyboard |
| Jakob Loven | |
|---|---|
| Firm | |
| Address | c/o Nextech Invest AG Bahnhofstrasse 18 Zurich, V8 CH-8001 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Juvia I Coinvest A LP | 021-591812 | Executive Officer | 13.0 M | ||
| Nextech VIII Carry SCSP | 021-530811 | Executive Officer | |||
| Iconovir Bio Inc | 021-484703 | Director | 20.2 M of 20.2 M |
||
| A2 Biotherapeutics Inc | 021-465076 | Director | 71.6 M of 71.6 M |
||
| Hexagon Bio Inc | 021-461285 | Director | 67.3 M of 80.0 M |
||
| Hexagon Bio Inc | 021-406716 | Director | 61.0 M | ||
| Vividion Therapeutics Inc | 021-390895 | Director | 135.0 M of 135.0 M |
||
| Iconovir Bio Inc | 021-383121 | Director | 77.0 M of 77.0 M |
||
| A2 Biotherapeutics Inc | 021-378361 | Director | 71.5 M of 71.5 M |
||
| Arvinas Inc | 021-344713 | Director | 32.5 M of 32.5 M |
||
| Vividion Therapeutics Inc | 021-338900 | Director | 82.0 M of 82.0 M |
||
| Arrakis Therapeutics Inc | 021-337635 | Director | 15.0 M of 75.0 M |
||
| Arvinas Holding Company LLC | 021-309449 | Director | 55.0 M of 55.0 M |
||
| Nextech Invest Ltd | |||||
| Nextech VIII SCSP | 021-526445 | Executive Officer | 297.5 M | 538.0 M | |